Unifying electron transfer mechanism for psilocybin and psilocin - Kovacic Peter (Medical Hypotheses, 2009)

Availability of websites offering to sell psilocybin spores and psilocybin. - Lott JP; Marlowe DB; Forman RF (Journal of psychoactive drugs, 2009)

Effects of Psilocybe argentipes on marble-burying behavior in mice. - Matsushima Y; Shirota O; Kikura-Hanajiri R; Goda Y; Eguchi F (Bioscience, biotechnology, and biochemistry, 2009)

Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. - Björnstad K; Hultén P; Beck O; Helander A (Clinical toxicology (Philadelphia, Pa.), 2009)

Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006. - Barbee G; Berry-Cabán C; Barry J; Borys D; Ward J; Salyer S (Journal of medical toxicology: official journal of the American College of Medical Toxicology, 2009)

[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS]. - Kawamura M; Kikura-Hanajiri R; Goda Y (Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 2009)

Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi. - Nef HM; Möllmann H; Hilpert P; Krause N; Troidl C; Weber M; Rolf A; Dill T; Hamm C; Elsässer A (International journal of cardiology, 2009)

[Mushroom poisoning–the dark side of mycetism]. - Flammer R; Schenk-Jäger KM (Therapeutische Umschau. Revue therapeutique, 2009)

A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. - Björnstad K; Beck O; Helander A (Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009)

GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. - Hasler F; Kuznetsova OF; Krasikova RN; Cservenyak T; Quednow BB; Vollenweider FX; Ametamey SM; Westera G (Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine, 2009)

[Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan]. - Gonmori K; Yokoyama K (Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2009)

Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions - Hasan Rafati; Hossein Riahi; Ali Mohammadi (International journal of medicinal mushrooms, 2009)

Psilocybin: Historical and pharmacological perspective and current authorized research - David Serrano Hurtado (Repositorio Universidad de Caldas, 2009)

Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching Laboratory - Brandon Huskins; Christopher R. Dockery (The Chemical Educator, 2009)

Agonist-trafficking and hallucinogens. - González-Maeso J; Sealfon SC (Current medicinal chemistry, 2009)

Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety. - Adams JD (Current medicinal chemistry, 2009)

Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships. - Kovacic P; Somanathan R (Oxidative medicine and cellular longevity, 2009)

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines - J.C. Winter (Psychopharmacology, 2008)

Unrecognized magic mushroom abuse in a 28-year-old man. - McClintock RL; Watts DJ; Melanson S (The American journal of emergency medicine, 2008)

Serotonin research: contributions to understanding psychoses. - Geyer MA; Vollenweider FX (Trends in pharmacological sciences, 2008)

The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists. - Bray JK; Goddard WA (Journal of molecular graphics & modelling, 2008)

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. - Griffiths R; Richards W; Johnson M; McCann U; Jesse R (Journal of psychopharmacology (Oxford, England), 2008)

Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans - F.X. Vollenweider; Daniel Hell; Michael Kometer (International Journal of Psychophysiology, 2008)

Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI - Danuta Marona-Lewicka; Benjamin R. Chemel; David E. Nichols (Psychopharmacology, 2008)

Benefits of 'magic mushroom' therapy long lasting - Arran Frood (Nature, 2008)

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. - Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E (Psychopharmacology, 2008)

[Hallucinogen-induced psychological disorders]. - Hermle L; Kovar KA; Hewer W; Ruchsow M (Fortschritte der Neurologie-Psychiatrie, 2008)

II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats - Wojciech Kostowski; W Rewerski; T Piechocki (Pharmacology, 2008)

Psychophysische Korrelationen unter der Einwirkung von Psycholytika (LSD, Psilocybin und ähnl.) - H. Holfeld (Medicina Experimentalis, 2008)

Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85-100 - H. Heimann (Psychiatria et Neurologia, 2008)

Klinische Erfahrungen mit Psilocybin (CY39 Sandoz) - M. Sercl; J Kovarik; O. Jaros (Psychiatria et Neurologia, 2008)

Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69-84 - H Heimann (Psychiatria et Neurologia, 2008)

Effects of varied doses of psilocybin on time interval reproduction in human subjects. - Wackermann J; Wittmann M; Hasler F; Vollenweider FX (Neuroscience letters, 2008)

Identification of a serotonin/glutamate receptor complex implicated in psychosis. - González-Maeso J; Ang RL; Yuen T; Chan P; Weisstaub NV; López-Giménez JF; Zhou M; Okawa Y; Callado LF; Milligan G; Gingrich JA; Filizola M; et al. (Nature, 2008)

Entheogens and the Public Mystery: The Rhetoric of R. Gordon Wasson - Antonio Ceraso (Configurations, 2008)

Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity. - Lee IK; Cho SM; Seok SJ; Yun BS (Mycobiology, 2008)

Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder - J.C. Ballenger (Yearbook of Psychiatry and Applied Mental Health, 2008)

The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin - William A. Richards (Archive for the Psychology of Religion, 2008)

Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. - Fantegrossi WE; Reissig CJ; Katz EB; Yarosh HL; Rice KC; Winter JC (Pharmacology, biochemistry, and behavior, 2008)

Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs. - Winter JC (Pharmacology, biochemistry, and behavior, 2008)

Between prohibitions: patterns and meanings of magic mushroom use in the UK. - Riley SC; Blackman G (Substance use & misuse, 2008)

The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin - Louis Garraway; Rean Maharaj (Living World, Journal of the Trinidad and Tobago Field Naturalists' Club, 2007)

Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis - Briony J. Catlow (Digital Commons - University of South Florida (University of South Florida), 2007)

[Automutilation after consumption of hallucinogenic mushrooms]. - Attema-de Jonge ME; Portier CB; Franssen EJ (Nederlands tijdschrift voor geneeskunde, 2007)

Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. - Carter OL; Hasler F; Pettigrew JD; Wallis GM; Liu GB; Vollenweider FX (Psychopharmacology, 2007)

Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. - Marona-Lewicka D; Nichols DE (Pharmacology, biochemistry, and behavior, 2007)

Psilocybin-induced stimulus control in the rat. - Winter JC; Rice KC; Amorosi DJ; Rabin RA (Pharmacology, biochemistry, and behavior, 2007)

Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. - del Mar Ramirez Fernandez M; Laloup M; Wood M; De Boeck G; Lopez-Rivadulla M; Wallemacq P; Samyn N (Journal of analytical toxicology, 2007)

Mad Thoughts on Mushrooms: Discourse and Power in the Study of Psychedelic Consciousness - Andy Letcher (Anthropology of Consciousness, 2007)

The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. - Vollenweider FX; Csomor PA; Knappe B; Geyer MA; Quednow BB (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2007)

Psilocybin Results Inspire Researchers - TIMOTHY F. KIRN (Clinical Psychiatry News, 2007)

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis. - Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E (Journal of psychopharmacology (Oxford, England), 2007)

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. - González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA (Neuron, 2007)

HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis - Veniero Gambaro; Lucia Dell’Acqua; P.F. Croci; CM Pecoraro (Meeting on Recent Developments in Pharmaceutical Analysis, 2007)

5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. - McCambridge J; Winstock A; Hunt N; Mitcheson L (European addiction research, 2007)

[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine]. - Majdanik S; Borowiak K; Brzezńska M; Machoy-Mokrzyńska A (Annales Academiae Medicae Stetinensis, 2007)

[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR]. - Adamczyk A; Sadakierska-Chudy A; Janoszka J; Rymkiewicz A; Dobosz T (Archiwum medycyny sadowej i kryminologii, 2007)

Detection and determination of abused hallucinogens in biological material. - Ondra P; Zedníková K; Válka I (Neuro endocrinology letters, 2006)

The adverse effects of hallucinogens from intramural perspective. - Frecska E; Luna LE (Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2006)

Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II). - Maruyama T; Kawahara N; Yokoyama K; Makino Y; Fukiharu T; Goda Y (Forensic science international, 2006)

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. - Moreno FA; Wiegand CB; Taitano EK; Delgado PL (The Journal of clinical psychiatry, 2006)

Hallucinogen research inspires “neurotheology” - Kelly Morris (The Lancet Neurology, 2006)

Hallucinogens - David L. Eldridge; Karin Hillenbrand (Pediatrics in Review, 2006)

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. - Griffiths RR; Richards WA; McCann U; Jesse R (Psychopharmacology, 2006)

PSILOCYBIN STUDIES TURN A NEW LEAF - Ivan Amato (Chemical & Engineering News, 2006)

Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - Herbert D. Kleber (Psychopharmacology, 2006)

Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - Charles R. Schuster (Psychopharmacology, 2006)

Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - David E. Nichols (Psychopharmacology, 2006)

Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - Solomon H. Snyder (Psychopharmacology, 2006)

Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user - Kamata Tooru; Nishikawa Mayumi; Katagi Munehiro; Tsuchihashi Hitoshi (Forensic Toxicology, 2006)

Response of cluster headache to psilocybin and LSD. - Sewell RA; Halpern JH; Pope HG (Neurology, 2006)

Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens. - Jensen N; Gartz J; Laatsch H (Planta medica, 2006)

Patterns of simultaneous polysubstance use in drug using university students. - Barrett SP; Darredeau C; Pihl RO (Human psychopharmacology, 2006)

Values and beliefs of psychedelic drug users: a cross-cultural study. - Lerner M; Lyvers M (Journal of psychoactive drugs, 2006)

Psilocin Identified in a DUID Investigation - Tiscione N. B.; Miller M. I. (Journal of Analytical Toxicology, 2006)

Effects of psilocybin on time perception and temporal control of behaviour in humans. - Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX. (Queensland's institutional digital repository (The University of Queensland), 2006)

Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography - Anastos N.; Barnett N.W.; Pfeffer F.M.; Lewis S.W. (Science & Justice, 2006)

Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor - M. Braden; James J. Chambers; David E. Nichols (The FASEB Journal, 2006)

Can mushrooms help save the world? Interview by Bonnie J. Horrigan. - Stamets P (Explore (New York, N.Y.), 2006)

Psilocin multiple intake resulted and in cardiotoxic effects - Krzysztof Borowiak; Anna Machoy-Mokrzyńska; Sławomir Majdanik; Piotr Waloszczyk; Małgorzata Piasecka; Tomasz Janus; E. Jasionowicz-Piatek; Mirosław Parafiniuk (Acta Toxicologica, 2006)

[Chronic cluster headache: Response to psilocybin]. - Sempere AP; Berenguer-Ruiz L; Almazán F (Revista de neurologia, 2006)

The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′-bipyridyl)ruthenium(II) Chemiluminescence Detection System - Anastos Nicole; Lewis Simon W.; Barnett Neil W.; Sims D. Noel (Journal of Forensic Sciences, 2006)

SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist. - Howard Sard; Govindaraj Kumaran; Cynthia Morency; Bryan L. Roth; Beth Ann Toth; Ping He; Louis Shuster (ChemInform, 2005)

Personality Characteristics of Adolescents with Hallucinogen, Methamphetamine, and Cannabis Dependence: A Comparative Study - Glen A. Palmer; Doyle D. Daiss (Journal of Child & Adolescent Substance Abuse, 2005)

Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse. - Bickel M; Ditting T; Watz H; Roesler A; Weidauer S; Jacobi V; Gueller S; Betz C; Fichtlscherer S; Stein J (European journal of emergency medicine: official journal of the European Society for Emergency Medicine, 2005)

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. - Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA (Pharmacopsychiatry, 2005)

SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist. - Sard H; Kumaran G; Morency C; Roth BL; Toth BA; He P; Shuster L (Bioorganic & medicinal chemistry letters, 2005)

Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. - Soyka M; Koch W; Möller HJ; Rüther T; Tatsch K (European archives of psychiatry and clinical neuroscience, 2005)

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. - Carter OL; Burr DC; Pettigrew JD; Wallis GM; Hasler F; Vollenweider FX (Journal of cognitive neuroscience, 2005)

Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis - Euphrosyne Gouzoulis-Mayfrank; Anna Neukirch; Karsten Heekeren (Pharmacopsychiatry, 2005)

B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION - Palenicek T.; Bubenikova V.; Votava M. (Behavioural Pharmacology, 2005)

Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectively - ANASTOS N; BARNETT N; LEWIS S; GATHERGOOD N; SCAMMELLS P; SIMS D (Talanta, 2005)

Hallucinogen persisting perception disorder after psilocybin consumption: a case study. - Espiard ML; Lecardeur L; Abadie P; Halbecq I; Dollfus S (European psychiatry: the journal of the Association of European Psychiatrists, 2005)

Can psychedelics have a role in psychiatry once again? - Ben Sessa (The British Journal of Psychiatry, 2005)

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. - Carter OL; Pettigrew JD; Hasler F; Wallis GM; Liu GB; Hell D; Vollenweider FX (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2005)

Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection. - Saito K; Toyo'oka T; Kato M; Fukushima T; Shirota O; Goda Y (Talanta, 2005)

[DNA and chemical analyses of commercial fly agaric-related products]. - Maruyama T; Kawahara N; Fukiharu T; Yokoyama K; Makino Y; Goda Y (Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan, 2005)

Liquid Chromatography-Mass Spectrometric and Liquid Chromatography-Tandem Mass Spectrometric Determination of Hallucinogenic Indoles Psilocin and Psilocybin in “Magic Mushroom” Samples - Kamata T; Nishikawa M; Katagi M; Tsuchihashi H (Journal of Forensic and Sciences, 2005)

Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples. - Kamata T; Nishikawa M; Katagi M; Tsuchihashi H (Journal of forensic sciences, 2005)

Substance abuse on the college campus. - Rimsza ME; Moses KS (Pediatric clinics of North America, 2005)

Response consistency in young adolescents' drug use self-reports: a recanting rate analysis. - Percy A; McAlister S; Higgins K; McCrystal P; Thornton M (Addiction (Abingdon, England), 2005)

Study on the biological characteristics and cultivation of panaeolus bisporus - He Xinsheng. (Wei sheng wu xue tong bao, 2005)

The noetic connection: synaesthesia, psychedelics, and language - Diana Slattery (Digital Creativity, 2004)

Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry - Saito Kimie; Toyo’oka Toshimasa; Fukushima Takeshi; Kato Masaru; Shirota Osamu; Goda Yukihiro (Analytica Chimica Acta, 2004)

Development of a psilocin immunoassay for serum and blood samples - Albers C.; Khler H.; Lehr M.; Brinkmann B.; Beike J. (International Journal of Legal Medicine, 2004)

Psilocybin impairs high-level but not low-level motion perception. - Carter OL; Pettigrew JD; Burr DC; Alais D; Hasler F; Vollenweider FX (Neuroreport, 2004)

The Meixner test in the detection of α-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines - Beuhler Michael; Lee David C.; Gerkin Richard (Annals of Emergency Medicine, 2004)

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. - Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J (Addictive behaviors, 2004)

Hallucinogens and dissociative agents naturally growing in the United States. - Halpern JH (Pharmacology & therapeutics, 2004)

Forensic analysis of hallucinogenic fungi: a DNA-based approach. - Nugent KG; Saville BJ (Forensic science international, 2004)

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. - Hasler F; Grimberg U; Benz MA; Huber T; Vollenweider FX (Psychopharmacology, 2004)

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. - Fantegrossi WE; Woods JH; Winger G (Behavioural pharmacology, 2004)

Khat and mushrooms associated with psychosis. - Nielen RJ; van der Heijden FM; Tuinier S; Verhoeven WM (The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry, 2004)

Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin - Yamaguchi Mitsune; Saito Toshiaki; Horiguchi Yoshie; Ogawa Keita; Tsuchiya Yukihiro; Hishinuma Kayoko; Chikuma Toshiyuki; Makino Yukiko; Hojo Hiroshi (Journal of Health Science, 2004)

The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds - O. Carter; David Alais; David C. Burr; Felix Hasler; G. Liu; Guy Wallis; Franz X. Vollenweider; John D. Pettigrew (Queensland's institutional digital repository (The University of Queensland), 2003)

Morphological and chemical analysis of magic mushrooms in Japan. - Tsujikawa K; Kanamori T; Iwata Y; Ohmae Y; Sugita R; Inoue H; Kishi T (Forensic science international, 2003)

Designer Hallucinogens - Leon Gussow (Emergency Medicine News, 2003)

Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples - Kamata Tooru; Nishikawa Mayumi; Katagi Munehiro; Tsuchihashi Hitoshi (Journal of Chromatography B, 2003)

P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis - Felix Hasler; Ulrike Grimberg; Martin Benz; F.X. Vollenweider (European Neuropsychopharmacology, 2003)

[Acute higher funghi mushroom poisoning and its treatment]. - Saviuc P; Flesch F (Presse medicale (Paris, France: 1983), 2003)

Psychoactive drugs and quality of life. - Ventegodt S; Merrick J (TheScientificWorldJournal, 2003)

[Levels of psilocybin and psilocin in various types of mushrooms]. - Stríbrný J; Borovicka J; Sokol M (Soudni lekarstvi, 2003)

[Hallucinogens, amphetamines and entactogens]. - Vollenweider FX; Vollenweider-Scherpenhuyzen MF (Therapeutische Umschau. Revue therapeutique, 2003)

Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom” - Shirota Osamu; Hakamata Wataru; Goda Yukihiro (Journal of Natural Products, 2003)

The examination of mushroom poisonings at Akita University. - Gonmori K; Yoshioka N (Legal medicine (Tokyo, Japan), 2003)

Preparation of the 4-Hydroxytryptamine Scaffold via Palladium-Catalyzed Cyclization: A Practical and Versatile Synthesis of Psilocin - Gathergood Nicholas; Scammells Peter J. (Organic Letters, 2003)

[Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region]. - Maruyama T; Shirota O; Kawahara N; Yokoyama K; Makino Y; Goda Y (Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan, 2003)

The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart - Anna Machoy-Mokrzyńska; Krzysztof Safranow; Krzysztof Borowiak; Sławomir Majdanik; Violetta Dziedziejko; Monika Białecka; Dariusz Chlubek (Acta Toxicologica, 2003)

Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms - Krzysztof Borowiak; Anna Machoy-Mokrzyńska; Leszek Domański; Sławomir Majdanik; Edward Dutkiewicz; K Safranow; Tomasz Janus; V Mikolajek (Acta Toxicologica, 2003)

A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicity - O. Carter; Shaun P. Collin; Felix Hasler; George Liu; Franz X. Vollenweider; John D. Pettigrew (Social Neuroscience, 2003)

Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. - Umbricht D; Vollenweider FX; Schmid L; Grübel C; Skrabo A; Huber T; Koller R (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2003)

[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs]. - Carod Artal FJ (Revista de neurologia, 2003)

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. - Riba J; Rodríguez-Fornells A; Barbanoj MJ (Psychopharmacology, 2002)

Psychotropic drugs in developmental mushrooms: a case study review. - Gross ST (Journal of forensic sciences, 2002)

The pharmacology of psilocybin. - Passie T; Seifert J; Schneider U; Emrich HM (Addiction biology, 2002)

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man - Hasler Felix; Bourquin Daniel; Brenneisen Rudolf; Vollenweider Franz X (Journal of Pharmaceutical and Biomedical Analysis, 2002)

Synthesis of a psilocin hapten and a protein-hapten conjugate - Albers Christian; Lehr Matthias; Beike Justus; Köhler Helga; Brinkmann Bernd (Journal of Pharmacy and Pharmacology, 2002)

Ecstasy and drug consumption patterns: a Canadian rave population study. - Gross SR; Barrett SP; Shestowsky JS; Pihl RO (Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002)

ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position. - Yamada Fumio; Tamura Mayumi; Hasegawa Atsuko; Somei Masanori (ChemInform, 2002)

5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens. - Rabin RA; Regina M; Doat M; Winter JC (Pharmacology, biochemistry, and behavior, 2002)

Drugs of abuse monitoring in blood for control of driving under the influence of drugs. - Moeller MR; Kraemer T (Therapeutic drug monitoring, 2002)

What geometric visual hallucinations tell us about the visual cortex. - Bressloff PC; Cowan JD; Golubitsky M; Thomas PJ; Wiener MC (Neural computation, 2002)

Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. - Umbricht D; Koller R; Vollenweider FX; Schmid L (Biological psychiatry, 2002)

Possible mechanisms of panic attack and schizophrenia via APUD system. - Fukuda K (Medical hypotheses, 2002)

Identifying the presence of ‘magic mushrooms’ by DNA profiling - Adrian Linacre; Michael D. Cole; Lee Jc (Science & Justice, 2002)

Entheogens and Existential Intelligence: The Use of Plant Teachers as Cognitive Tools - Kenneth W. Tupper (Canadian Journal of Education / Revue canadienne de l éducation, 2002)

Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans. - Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M (Neuropsychobiology, 2002)

Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity. - ten Berge J (Journal of psychoactive drugs, 2002)

Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position. - Yamada Fumio; Tamura Mayumi; Hasegawa Atsuko; Somei Masanori (Chemical and Pharmaceutical Bulletin, 2002)

Brain mechanisms of hallucinogens and entactogens. - Vollenweider FX (Dialogues in clinical neuroscience, 2001)

A systems model of altered consciousness: integrating natural and drug-induced psychoses. - Vollenweider FX; Geyer MA (Brain research bulletin, 2001)

Patterns of recreational drug use at dance events in Edinburgh, Scotland. - Riley SC; James C; Gregory D; Dingle H; Cadger M (Addiction (Abingdon, England), 2001)

The Detection of Psilocin in Human Urine - Grieshaber AF; Moore KA; Levine B (Journal of Forensic Sciences, 2001)

The detection of psilocin in human urine. - Grieshaber AF; Moore KA; Levine B (Journal of forensic sciences, 2001)

Towards a molecular approach for the identification of fungal taxa that contain psilocybin - Lee JC. (University of Strathclyde, 2001)

The effect of Psilocybe cubensis extract on hippocampal neurons in vitro. - Moldavan MG; Grodzinskaya AA; Solomko EF; Lomberh ML; Wasser SP; Storozhuk VM (Fiziolohichnyi zhurnal (Kiev, Ukraine: 1994), 2001)

Drug addiction. Part I. Psychoactive substances in the past and presence. - Vetulani J (Polish journal of pharmacology, 2001)

Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). - Ho E; Karimi-Tabesh L; Koren G (Neurotoxicology and teratology, 2000)

The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review. - Salomé F; Boyer P; Fayol M (European psychiatry: the journal of the Association of European Psychiatrists, 2000)

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. - Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE (Journal of medicinal chemistry, 2000)

Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. - Bogusz MJ (Journal of chromatography. B, Biomedical sciences and applications, 2000)

[Intoxications by hallucinogenic mushrooms]. - Pierrot M; Josse P; Raspiller MF; Goulmy M; Rambourg MO; Manel J; Lambert H (Annales de medecine interne, 2000)

Hallucinogenic drugs attenuate the subjective response to alcohol in humans. - Barrett SP; Archambault J; Engelberg MJ; Pihl RO (Human psychopharmacology, 2000)

Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. - Musshoff F; Madea B; Beike J (Forensic science international, 2000)

Detection of psilocin in body fluids - Sticht G; Käferstein H (Forensic Science International, 2000)

Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey. - Adlaf EM; Paglia A; Ivis FJ; Ialomiteanu A (CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000)

Detecting psychoactive drugs in the developmental stages of mushrooms. - Gross ST (Journal of forensic sciences, 2000)

[Development of synthetic methods for 4-substituted indoles and their applications for the syntheses of natural products]. - Yamada F (Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 2000)

177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia - Daniel Umbricht; F.X. Vollenweider; L. Schmid; R. Koller (Biological Psychiatry, 2000)

Multifocal cerebral demyelination after magic mushroom abuse. - Spengos K; Schwartz A; Hennerici M (Journal of neurology, 2000)

Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies - M. G. Moldavan; Elvira F. Solomko; Anna A. Grodzínskaya; V. М. Storozhuk; Margarita Lomberg (International journal of medicinal mushrooms, 2000)

TRAGIC FLYING ATTEMPT UNDER THE INFLUENCE OF "MAGIC MUSHROOMS" - Gilbert Asselborn; Robert Wennig; Michel Yegles (Problems of Forensic Sciences, 2000)

[Microscopic study of powders of hallucinogenic mushrooms–Psilocybe sp]. - Schäfer AT (Archiv fur Kriminologie, 2000)

Bufotenine: toward an understanding of possible psychoactive mechanisms. - McBride MC (Journal of psychoactive drugs, 2000)

Panaeolus bisporus - an adventitious fungus in central Europe, rich in psilocin - Senn-Irlet Beatrice; Nyffenegger Adolf; Brenneisen Rudolf (Mycologist, 1999)

Chromatographic screening techniques in systematic toxicological analysis. - Drummer OH (Journal of chromatography. B, Biomedical sciences and applications, 1999)

Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain. - Gerasimov M; Marona-Lewicka D; Kurrasch-Orbaugh DM; Qandil AM; Nichols DE (Journal of medicinal chemistry, 1999)

Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometry - Keller T; Schneider A; Regenscheit P; Dirnhofer R; Rucker T; Jaspers J; Kisser W (Journal of Clinical Forensic Medicine, 1999)

On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine. - Krämer E; Kovar KA (Journal of chromatography. B, Biomedical sciences and applications, 1999)

ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin. - Nichols David E.; Frescas Steward (ChemInform, 1999)

ChemInform Abstract: A New Synthesis of Psilocin - Sakagami Hideki; Ogasawara Kunio (ChemInform, 1999)

[Biological addictive drugs–is there a change in drug taking behavior of young drug addicts?]. - Löhrer F; Albers M (Psychiatrische Praxis, 1999)

ChemInform Abstract: Chemistry of Indoles. Part 88. A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde. - Yamada Fumio; Tamura Mayumi; Somei Masanori (ChemInform, 1999)

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. - Gouzoulis-Mayfrank E; Schreckenberger M; Sabri O; Arning C; Thelen B; Spitzer M; Kovar KA; Hermle L; Büll U; Sass H (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 1999)

Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin - Nichols David E. (Synthesis, 1999)

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man–a PET study with [11C]raclopride. - Vollenweider FX; Vontobel P; Hell D; Leenders KL (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 1999)

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. - Gouzoulis-Mayfrank E; Thelen B; Habermeyer E; Kunert HJ; Kovar KA; Lindenblatt H; Hermle L; Spitzer M; Sass H (Psychopharmacology, 1999)

South African fungi 9: Psilocybe natalensis - a blueing hallucinogenic species from South Africa - D A Reid; A. Eicker (Mycotaxon, 1999)

H-D Exchange of Psilocin and Its Analogs - Shirahama Haruhisa; Sogawa Kazuyo; Hashimoto Kimiko (HETEROCYCLES, 1999)

Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMÁN by ion mobility spectrometry and gas chromatography-mass spectrometry - Keller Thomas; Schneider Andrea; Regenscheit Priska; Richard Dirnhofer; Rücker Thomas; Jaspers Jürgen; Kisser Wolfgang (Forensic Science International, 1999)

[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms]. - Babakhanian RV; Ivanova GV; Kostyrko TA; Safraĭ AE; Iagmurov OD (Sudebno-meditsinskaia ekspertiza, 1999)

A New Synthesis of Psilocin - Ogasawara Kunio; Sakagami Hideki (HETEROCYCLES, 1999)

Capillary electrophoresis of psilocybin in hallucinogenic mushrooms - Stig Pedersen-Bjergaard; Knut Einar Rasmussen (Research at the University of Copenhagen (University of Copenhagen), 1998)

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. - Vollenweider FX; Vollenweider-Scherpenhuyzen MF; Bäbler A; Vogel H; Hell D (Neuroreport, 1998)

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans. - Gouzoulis-Mayfrank E; Heekeren K; Thelen B; Lindenblatt H; Kovar KA; Sass H; Geyer MA (Behavioural pharmacology, 1998)

Recent findings from the Ontario Student Drug Use Survey. - Adlaf EM; Ivis FJ (CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998)

529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans - Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; B. Thelen; Hiltrud Lindenblatt; K.-A. Kovar; H. Sass; M.A. Geyer (International Journal of Psychophysiology, 1998)

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. - Vollenweider FX (Pharmacopsychiatry, 1998)

Methodological issues of human experimental research with hallucinogens. - Gouzoulis-Mayfrank E; Schneider F; Friedrich J; Spitzer M; Thelen B; Sass H (Pharmacopsychiatry, 1998)

11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation - Ametamey S.; Vollenweider F. X.; Patt J.; Bourquin D.; Hasler F.; Beer H.-F.; Schubiger P. A. (Journal of Labelled Compounds and Radiopharmaceuticals, 1998)